Kourosh Davarpanah, Inato CEO
March 29, 2023 03:10 PM EDT
Financing
Pharma

Big Phar­ma-part­nered clin­i­cal tri­al match­mak­er se­cures $20M to im­prove plat­form

Paul Schloesser

Associate Editor

A com­pa­ny with pub­lic links to Sanofi and Mod­er­na has raised more mon­ey to ex­pand its mis­sion of im­prov­ing di­ver­si­ty and en­roll­ment in clin­i­cal tri­als …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times